NCT01199900 - Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Healthy

Interventions

DRUG

PF-04171327

25 mg extemporaneous preparation of oral solution predosed 8 hours prior to Oral Glucose Tolerance Test (OGTT)

DRUG

PF-04171327

25 mg extemporaneous preparation of oral solution predosed 12 hours prior to Oral Glucose Tolerance Test (OGTT)

DRUG

Prednisone

5 mg tablet predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)

DRUG

PF-04171327

3 mg extemporaneous preparation of oral solution predosed at time selected from Part 1 prior to Oral Glucose Tolerance Test (OGTT)

DRUG

PF-04171327

10 mg extemporaneous preparation of oral solution predosed at time selected from Part 1 prior to Oral Glucose Tolerance Test (OGTT)

DRUG

Prednisone

5 mg tablet predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)

DRUG

Prednisone

5 mg tablets predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)

Trial Locations (1)

Pfizer Investigational Site, Kalamazoo